According to the latest report by IMARC Group, titled “Viral Inactivation Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the global viral inactivation market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 11% during 2021-2026.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Request Free Report Sample: https://www.imarcgroup.com/viral-inactivation-market/requestsample
Viral inactivation is the process of completely inhibiting the growth of viruses and contamination from the selected biotherapeutic commodity during the manufacturing process. This technique is extensively deployed in food and blood plasma sectors, as it can be affected by the presence of viral particles. The viral inactivation consists of various virus-removal approaches, such as chromatography, nanofiltration and precipitation. These approaches are implemented based on the size, lability, and type of biotherapeutic product.
The increasing prevalence of infectious diseases represents one of the key factors primarily driving the market growth. Moreover, numerous initiatives undertaken by the government of various countries for modernizing healthcare infrastructure are propelling the market growth. Other factors, such as the continual launch of new drugs and various therapeutic products, extensive research and development (R&D) activities, and the rising consciousness amongst consumers regarding the transmission of blood-borne viruses via plasma, are creating a positive outlook for the market.
Viral Inactivation Market 2021-2026 Competitive Analysis and Segmentation:
Competitive Landscape With Key Players:
The competitive landscape of the global viral inactivation market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
- Charles River Laboratories
- Merck KGaA
- Parker Hannifin Corp
- Rad Source Technologies
- Sartorius AG
- SGS SA
- Terumo Corporation
- Texcell
- Vironova AB
- WuXi AppTec
Key Market Segmentation:
The report has segmented the global viral inactivation market on the basis of product, application, end use and region.
Breakup by Product:
- Reagents and Kits
- Systems
- Services
Breakup by Application:
- Vaccines and Therapeutics
- Stem Cell Products
- Blood and Blood Products
- Tissue and Tissue Products
- Cellular and Gene Therapy
Breakup by End Use:
- Pharmaceutical and Biotechnology Companies
- CROs
- Academic and Research Institutes
- Others
Breakup by Region:
- North America
- Asia-Pacific
- Europe
- Latin America
- Middle East and Africa
Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/viral-inactivation-market
Key highlights of the report:
- Market Performance (2015-2020)
- Market Outlook (2021-2026)
- Industry Trends
- Market Drivers and Success Factors
- The Impact of COVID-19 on the Global Market
- Value Chain Analysis
- Structure of the Global Market
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800
The legal age to purchase and use marijuana in Canada is 19 Buy cheap weed online in canada years of age.
One of the main benefits of using an buy weed online canada is the convenience it offers. Customers can browse products, place orders, and have them delivered to their doorstep, all from the comfort of their own homes. This is especially useful for those who live in remote areas, or who have mobility issues and find it difficult to travel to a physical dispensary.
This post post made me think. I will write something about this on my blog. Have a nice day!!